Acción 300529 JAFRON BIOMEDICAL CO.,LTD.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Jafron Biomedical Co.,Ltd.

Acciones

300529

CNE100002995

Precio de cierre Shenzhen S.E.
Otros sitios de cotización
 00:00:00 06/05/2024 		Varia. Cinco días. Varia. 1 de enero.
29,41 CNY +6,79 % Gráfico intradía de Jafron Biomedical Co.,Ltd. +8,52 % +32,30 %
25/04 Jafron Biomedical Co.,Ltd. informa de los resultados del primer trimestre finalizado el 31 de marzo de 2024 CI
2023 Jafron Biomedical Co.,Ltd. informa de los resultados de los nueve meses finalizados el 30 de septiembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Jafron Biomedical Co.,Ltd. Proposes Final Dividend for the Year 2023
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.
Jafron Biomedical Co.,Ltd.'s Equity Buyback announced on July 17, 2023, has closed with 24,242,904 shares, representing 3% for CNY 500 million.
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Zhuhai Jianfu Pharmaceutical Co., Ltd. announced that it expects to receive CNY 15 million in funding from Jafron Biomedical Co.,Ltd.
Tranche Update on Jafron Biomedical Co.,Ltd.'s Equity Buyback Plan announced on July 17, 2023.
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Jafron Biomedical Co.,Ltd. announces an Equity Buyback for CNY 500 million worth of its shares.
Jafron Biomedical Co.,Ltd. authorizes a Buyback Plan.
Jafron Biomedical Co.,Ltd. Announces Cash Dividend on A Shares for the Year 2022, Payable on 31 May 2023
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Jafron Biomedical Co.,Ltd. Approves the Cash Dividend for 2022
Jafron Biomedical Co.,Ltd. Approves Director Elections
Jafron Biomedical Co.,Ltd. Announces Profit Distribution Proposal for 2022
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Jafron Biomedical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 300529
  4. Noticias Jafron Biomedical Co.,Ltd.
  5. Otros idiomas